Patent Assignment
Reel/Frame 053172/0940
Merger
Recorded: 2020-07-10
Pages: 9
Assignor
TOLERO PHARMACEUTICALS, INC.
Executed: 2020-07-01
Assignee
BOSTON BIOMEDICAL, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(18)
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms and Fibrosis Associated with Cancer
PCT:
PCT/US2019/027217 ↗
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
PCT:
PCT/US2020/017981 ↗
Imidazo[1,2-Beta]Pyridazine and Pyrazolo[1,5-Alpha]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Methods and Compounds for Treating Pim-1 Kinase-Expressing Cancer Cells
Application:
12/785,322 →
Publication:
US 2010/0227861
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES AS PROTEIN KINASE INHIBITORS
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/632,834 →
Publication:
US 2012/0058997
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms
Application:
62/657,540 →
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms
Application:
62/657,563 →
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms and Fibrosis Associated with Cancer
Application:
62/743,469 →
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms and Fibrosis Associated with Cancer
Application:
62/753,023 →
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms
Application:
62/753,025 →
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Application:
62/804,556 →
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Application:
62/925,153 →
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Application:
62/962,833 →
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 28, 2008
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 020721/0348 →
Merger/Name Change
Feb 22, 2012
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS. INC.
Reel/Frame 027747/0334 →
Assignment of Assignor's Interest
Jul 26, 2012
From: ASTEX PHARMACEUTICALS, INC.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 028650/0717 →
Assignment of Assignor's Interest
Aug 12, 2014
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 033521/0153 →
Security Interest
Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Assignment of Assignor's Interest
Sep 18, 2018
From: BEARSS, DAVID J.; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 046898/0385 →
Assignment of Assignor's Interest
Feb 15, 2019
From: BEARSS, DAVID J.; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 048355/0964 →
Assignment of Assignor's Interest
Feb 15, 2019
From: BEARSS, DAVID J.; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 048356/0059 →
Assignment of Assignor's Interest
Feb 15, 2019
From: BEARSS, DAVID J.; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 048341/0285 →
Assignment of Assignor's Interest
May 15, 2019
From: FOULKS, JASON MARC; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049180/0782 →
Assignment of Assignor's Interest
Jul 17, 2019
From: FUJIWARA, YUJI; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049774/0294 →
Assignment of Assignor's Interest
Jan 27, 2020
From: FUJIWARA, YUJI; SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051625/0340 →
Assignment of Assignor's Interest
Jan 27, 2020
From: FUJIWARA, YUJI; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051707/0224 →
Assignment of Assignor's Interest
Mar 6, 2020
From: WARNER, STEVEN L.; SIDDIQUI-JAIN, ADAM; FLYNN, PAUL
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 052035/0192 →
Assignment of Assignor's Interest
Apr 27, 2020
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 052500/0211 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0718 →
Assignment of Assignor's Interest
Jul 10, 2020
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 053174/0964 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →